全文获取类型
收费全文 | 11160篇 |
免费 | 767篇 |
国内免费 | 74篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 192篇 |
妇产科学 | 196篇 |
基础医学 | 1202篇 |
口腔科学 | 142篇 |
临床医学 | 1475篇 |
内科学 | 1278篇 |
皮肤病学 | 114篇 |
神经病学 | 911篇 |
特种医学 | 817篇 |
外科学 | 1109篇 |
综合类 | 1111篇 |
一般理论 | 1篇 |
预防医学 | 1357篇 |
眼科学 | 197篇 |
药学 | 638篇 |
6篇 | |
中国医学 | 412篇 |
肿瘤学 | 783篇 |
出版年
2024年 | 26篇 |
2023年 | 643篇 |
2022年 | 1010篇 |
2021年 | 860篇 |
2020年 | 895篇 |
2019年 | 519篇 |
2018年 | 426篇 |
2017年 | 573篇 |
2016年 | 609篇 |
2015年 | 579篇 |
2014年 | 1106篇 |
2013年 | 648篇 |
2012年 | 500篇 |
2011年 | 408篇 |
2010年 | 595篇 |
2009年 | 528篇 |
2008年 | 220篇 |
2007年 | 209篇 |
2006年 | 166篇 |
2005年 | 115篇 |
2004年 | 94篇 |
2003年 | 104篇 |
2002年 | 105篇 |
2001年 | 87篇 |
2000年 | 64篇 |
1999年 | 127篇 |
1998年 | 128篇 |
1997年 | 85篇 |
1996年 | 114篇 |
1995年 | 87篇 |
1994年 | 53篇 |
1993年 | 55篇 |
1992年 | 21篇 |
1991年 | 30篇 |
1990年 | 33篇 |
1989年 | 28篇 |
1988年 | 27篇 |
1987年 | 44篇 |
1986年 | 40篇 |
1985年 | 15篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 2篇 |
1980年 | 1篇 |
1979年 | 5篇 |
1978年 | 1篇 |
1976年 | 2篇 |
1973年 | 1篇 |
1970年 | 1篇 |
1968年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
931.
932.
933.
Martin Dugas Sylvia Thun Thomas Frankewitsch Kai U. Heitmann 《J Am Med Inform Assoc》2009,16(3):400-403
Hospital Information Systems (HIS) handle a large number of different types of documents. Exchange and analysis of data from different HIS is facilitated by the use of standardized codes to identify document types. HL7's Clinical Document Architecture (CDA) uses LOINC (logical observation identifiers names and Codes) codes for clinical documents. The authors assessed the coverage of LOINC codes for document types in a German HIS. The authors analyzed document types that occurred more than 10 times in approximately 1.3 million documents in a commercial HIS at a major German University Hospital. Document types were mapped manually to LOINC using the Regenstrief LOINC Mapping Assistant (RELMA). Each document type was coded by two physicians. In case of discrepancies a third expert was consulted to reach consensus. For 76 of 86 document categories a LOINC code was identified, but for 38 of these categories, the LOINC code was not specific as deemed necessary. More than 93% of our local HIS documents had local document types that could be assigned a LOINC code. 相似文献
934.
《Pain Management Nursing》2008,9(3):131-140
The use of “as needed” or “pro re nata” (PRN) range opioid analgesic orders is a common clinical practice in the management of acute pain, designed to provide flexibility in dosing to meet an individual's unique needs. Range orders enable necessary adjustments in doses based on individual response to treatment. However, PRN range opioid orders have recently come under scrutiny as a source of confusion and as a medication management safety issue. How nurses administer range orders may vary based on their interpretation of the intent of an order, inadequate knowledge of analgesic titration, or exaggerated concerns about opioid safety. The purpose of this study was to investigate nurses' opinions of the appropriate implementation of range orders. Six hundred two nurses from one large academic medical center and one multihospital system completed an online survey using theoretic clinical vignettes to examine their opinions of appropriate analgesic administration practices. The majority of participants chose appropriate responses to the vignettes; however, there was a great deal of variability in responses. Those who had attended pain management courses were more likely to have a higher percentage of appropriate responses than those who had not attended courses. Years in practice and educational level were not significantly related to percentage of appropriate responses; however, there was a trend for nurses with a master's degree to have a higher percentage than nurses with other educational preparation. Consideration of opioid pharmacokinetics can provide logic to develop a new paradigm where range orders are replaced with orders that provide more explicit instructions to titrate an opioid to the most effective dose. 相似文献
935.
《Microvascular research》2011,81(3):552-555
Quantitative measurement of functional tissue perfusion is essential for early diagnosis and proper treatment of peripheral arterial occlusive disease (PAOD). We have previously demonstrated that dynamic imaging of near-infrared fluorophore indocyanine green (ICG) can be a noninvasive and sensitive tool to measure tissue perfusion. In the present study, we investigated the clinical efficacy of ICG perfusion imaging method for the diagnosis of PAOD. Total nineteen PAOD patients and age-matched controls (n = 10) were evaluated for lower extremity tissue perfusion using ICG perfusion imaging. The perfusion rates of the lower extremities with severe PAOD (n = 25 legs, 16.6 ± 8.3%/min) were significantly lower than those of normal controls (38.1 ± 17.3%/min, p < 0.001). In cases of mild PAOD, the perfusion rates (n = 11 legs, 18.3 ± 10.3%/min) were also significantly lower compared to the control; while the conventional ankle-brachial index (ABI) test failed to detect mild functional impairment. These results collectively indicate that ICG perfusion imaging can be a very effective tool for diagnosis of PAOD with a superior efficacy in comparison to conventional ABI test. 相似文献
936.
《Journal of Medical Imaging and Radiation Sciences》2008,39(1):11-15
Stress is one of the leading causes of mental and physical health problems in our society. This subject is nothing new to radiology professionals because of the constant exposure to various stressors. These stressors include staffing shortages, physical injuries, hospital violence, and diverse types of fatigue. Stressors are unique and personal to each individual, but they can also be applied to all radiology professionals and can correlate with health deficiencies. This paper examines research available on stress, and what stressors continuously affect the health of working professionals. To eliminate the negative effects of stressors, it is imperative for all health care providers to evaluate the bounds and risks to devise the most appropriate solution. 相似文献
937.
Ronald Emkey Pierre D. Delmas Michael Bolognese Joao Lindolfo C. Borges Felicia Cosman Sergio Ragi-Eis Christopher Recknor Cristiano A. Zerbini Colin Neate Farhad Sedarati Solomon Epstein 《Clinical therapeutics》2009,31(4):751-761
Background: The MOTION (Monthly Oral Therapy with Ibandronate for Osteoporosis Intervention) study reported that once-monthly ibandronate was noninferior to once-weekly alendronate in terms of increasing bone mineral density (BMD) at the lumbar spine and total hip over 12 months. On analysis of secondary and exploratory end points in MOTION, which included trochanter and femoral neck BMD, monthly ibandronate was found to be noninferior to weekly alendronate. The coprimary, secondary, and exploratory BMD end points from MOTION have been previously reported.Objective: This report presents additional results from the MOTION study, including response rates in terms of lumbar spine and total hip BMD gains above baseline; findings from a comparison of serum concentrations of bone turnover markers; and tolerability analysis, including adverse events that led to withdrawal and gastrointestinal (GI) adverse events.Methods: MOTION was a 12-month (with 15-day follow-up), randomized, multinational, multicenter, double-blind, double-dummy, parallel-group, nonin-feriority study in postmenopausal women aged 55 to <85 years with osteoporosis. Patients were randomly assigned to receive 150-mg-monthly oral ibandronate and weekly alendronate-matched placebo, or 70-mg-weekly oral alendronate and monthly ibandronate-matched placebo, for 12 months. At baseline, day 7 of treatment, 3 and 6 months, 6 months + 7 days, and 12 months, serum concentrations of markers of bone resorption (C-telopeptide of the a chain of type 1 collagen [sCTX]) and bone formation (serum N-terminal propeptides of type 1 collagen) were measured in a subset of the total trial population. At baseline and month 12, BMD was measured using dual-energy x-ray absorptiometry. Exploratory analyses of patients whose spine, total hip, and trochanter BMD at 12 months were above baseline (responders) were also performed.Results: A total of 1760 women were enrolled (ibandronate, 887 patients; alendronate, 873). The median changes in the trough concentrations of sCTX were ?75.5% with monthly ibandronate and ?81.2% with weekly alendronate. The percentage of patients with mean lumbar spine and total hip BMD gains above baseline (responders) were 90% and 87%, respectively, for ibandronate and 92% and 90%, respectively, for alendronate. GI adverse events were reported in ≤30% of patients per group during this 1-year study.Conclusion: The data from these postmenopausal women with osteoporosis suggest that once-monthly 150-mg ibandronate therapy provided clinically comparable efficacy in terms of BMD response, reductions in bone turnover, and GI tolerability similar to that of weekly 70-mg alendronate. 相似文献
938.
939.
通过对中文期刊文献数据库病毒性心肌炎疗效评价指标类型的分析,探讨病毒性心肌炎疗效评价指标现状产生的原因及存在问题。 相似文献
940.